Rheumatoid Arthritis Headlines

Topical vs Oral NSAIDs for Rheumatoid Arthritis: Examining Cardiovascular Risks

Topical vs Oral NSAIDs for Rheumatoid Arthritis: Examining Cardiovascular Risks

Researchers assessed the rates of composite cardiovascular events in people with RA using NSAIDs to treat musculoskeletal pain.

Prognostic Value of Thrombocytopenia in Valve Replacement Surgery for Rheumatic Heart Disease

Prognostic Value of Thrombocytopenia in Valve Replacement Surgery for Rheumatic Heart Disease

Presence of thrombocytopenia at hospital admission may serve as an important prognostic marker for predicting in-hospital mortality for patients with RHD.

Risk for COPD, Asthma Examined in Women With Rheumatoid Arthritis

Risk for COPD, Asthma Examined in Women With Rheumatoid Arthritis

RA-specific factors may predispose individuals to developing COPD independent of smoking.

Juvenile Idiopathic Arthritis Disease Activity Low but Stable During Pregnancy

Juvenile Idiopathic Arthritis Disease Activity Low but Stable During Pregnancy

An increase in disease activity 6 weeks postpartum suggests the need for tight follow-up of women with juvenile idiopathic arthritis.

Ixifi Gets FDA Approval for All Remicade Indications

Ixifi Gets FDA Approval for All Remicade Indications

The FDA has approved infliximab-qbtx as a biosimilar to infliximab for all indications of the reference drug.

Leflunomide Exposure During Pregnancy Not Associated With Increased Risk for Adverse Outcomes

Leflunomide Exposure During Pregnancy Not Associated With Increased Risk for Adverse Outcomes

The safety of leflunomide use for rheumatoid arthritis during pregnancy was examined in a prospective study.

New Studies Examine Potential Effects of Weight Loss, Obesity on Patient Health in RA

New Studies Examine Potential Effects of Weight Loss, Obesity on Patient Health in RA

Findings from 2 studies examine the role that weight loss, obesity, and overweight play in disease activity, remission, and mortality in RA.

New Survey to More Accurately Diagnose Arthritis

New Survey to More Accurately Diagnose Arthritis

The prevalence of arthritis in the United States may have been greatly underestimated, particularly in people younger than 65 years.

Classical Disease-Modifying Antirheumatic Drugs: A Possible Treatment Option for Dementia?

Classical Disease-Modifying Antirheumatic Drugs: A Possible Treatment Option for Dementia?

The protective effects of disease-modifying antirheumatic drugs in dementia was evaluated in a retrospective cohort study.

Characterization of Rheumatic Disorders Associated With Immune Checkpoint Inhibitor Use

Characterization of Rheumatic Disorders Associated With Immune Checkpoint Inhibitor Use

A prospective, observational study sought to evaluate and characterize the nature of rheumatic disorders associated with immune checkpoint inhibitors.

Clinical Outcomes With MTX Monotherapy vs TNFi-MTX Combination Therapy for Early RA

Clinical Outcomes With MTX Monotherapy vs TNFi-MTX Combination Therapy for Early RA

A randomized study sough to evaluate whether methotrexate monotherapy can safely be started before treatment optimization with a tumor necrosis factor inhibitor in patients with early, active RA.

Effect of bDMARD Discontinuation on Remission, Radiographic Progression in RA

Effect of bDMARD Discontinuation on Remission, Radiographic Progression in RA

In patients with RA who have achieved remission or low disease activity (LDA), discontinuation of biologic disease-modifying antirheumatic drugs is associated with an increased risk for losing remission or LDA and radiographic progression.

Pneumonia Incidence in Rheumatic Disease Lowered With Primary Prophylaxis

Pneumonia Incidence in Rheumatic Disease Lowered With Primary Prophylaxis

In patients with rheumatic diseases, the incidence of pneumocystis pneumonia was reduced with primary prophylaxis with trimethoprim/sulfamethoxazole.

Tocilizumab Reduces Bone Loss in ACPA-Positive Rheumatoid Arthritis

Tocilizumab Reduces Bone Loss in ACPA-Positive Rheumatoid Arthritis

Tocilizumab treatment for 2 years was shown to reduce levels of bone loss in patients with ACPA-positive RA.

Biologics Not Linked to Increased Risk of Second Malignancy in RA

Biologics Not Linked to Increased Risk of Second Malignancy in RA

Using biologics to treat rheumatoid arthritis patients does not appear to increase the risk of a second malignancy in individuals with history of cancer.

Early Treatment of Undifferentiated Arthritis May Delay Subsequent RA Progression

Early Treatment of Undifferentiated Arthritis May Delay Subsequent RA Progression

Early treatment of undifferentiated arthritis may delay progression to rheumatoid arthritis.

Serious Infections Uncommon in Patients With RA Treated With bDMARD With or Without Denosumab

Serious Infections Uncommon in Patients With RA Treated With bDMARD With or Without Denosumab

In patients with rheumatoid arthritis being treated with a biologic disease-modifying antirheumatic drug with and without denosumab, serious and opportunistic infections are uncommon.

Assessing Fear, Psychological Distress in Rheumatoid Arthritis and Axial Spondyloarthritis

Assessing Fear, Psychological Distress in Rheumatoid Arthritis and Axial Spondyloarthritis

The Fear Assessment in Inflammatory Rheumatic diseases questionnaire may be useful to evaluate the levels of fear and psychological distress in patients with rheumatoid arthritis and axial spondyloarthritis.

Risk for Prosthetic Joint Infection, Surgical Revision After Total Joint Arthroplasty in RA

Risk for Prosthetic Joint Infection, Surgical Revision After Total Joint Arthroplasty in RA

Patients with rheumatoid arthritis may be at increased risk for prosthetic joint infection and death after total knee or hip arthroplasty, compared with patients with osteoarthritis.

Increased Risk for COPD in Rheumatoid Arthritis

Increased Risk for COPD in Rheumatoid Arthritis

Patients with rheumatoid arthritis appear to be at increased risk for chronic obstructive pulmonary disease.

Sign Up for Free e-newsletters